2023-02-012024-01-312024-01-31false07430397MEDS AT HOME LIMITED2024-10-25iso4217:GBPxbrli:pure074303972023-02-01074303972024-01-31074303972023-02-012024-01-31074303972022-02-01074303972023-01-31074303972022-02-012023-01-3107430397bus:SmallEntities2023-02-012024-01-3107430397bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3107430397bus:FullAccounts2023-02-012024-01-3107430397bus:PrivateLimitedCompanyLtd2023-02-012024-01-3107430397core:WithinOneYear2024-01-3107430397core:AfterOneYear2024-01-3107430397core:WithinOneYear2023-01-3107430397core:AfterOneYear2023-01-3107430397core:ShareCapital2024-01-3107430397core:SharePremium2024-01-3107430397core:RevaluationReserve2024-01-3107430397core:OtherReservesSubtotal2024-01-3107430397core:RetainedEarningsAccumulatedLosses2024-01-3107430397core:ShareCapital2023-01-3107430397core:SharePremium2023-01-3107430397core:RevaluationReserve2023-01-3107430397core:OtherReservesSubtotal2023-01-3107430397core:RetainedEarningsAccumulatedLosses2023-01-3107430397core:LandBuildings2024-01-3107430397core:PlantMachinery2024-01-3107430397core:Vehicles2024-01-3107430397core:FurnitureFittings2024-01-3107430397core:OfficeEquipment2024-01-3107430397core:NetGoodwill2024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-01-3107430397core:ListedExchangeTraded2024-01-3107430397core:UnlistedNon-exchangeTraded2024-01-3107430397core:LandBuildings2023-01-3107430397core:PlantMachinery2023-01-3107430397core:Vehicles2023-01-3107430397core:FurnitureFittings2023-01-3107430397core:OfficeEquipment2023-01-3107430397core:NetGoodwill2023-01-3107430397core:IntangibleAssetsOtherThanGoodwill2023-01-3107430397core:ListedExchangeTraded2023-01-3107430397core:UnlistedNon-exchangeTraded2023-01-3107430397core:LandBuildings2023-02-012024-01-3107430397core:PlantMachinery2023-02-012024-01-3107430397core:Vehicles2023-02-012024-01-3107430397core:FurnitureFittings2023-02-012024-01-3107430397core:OfficeEquipment2023-02-012024-01-3107430397core:NetGoodwill2023-02-012024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3107430397core:ListedExchangeTraded2023-02-012024-01-3107430397core:UnlistedNon-exchangeTraded2023-02-012024-01-3107430397core:MoreThanFiveYears2023-02-012024-01-3107430397core:Non-currentFinancialInstruments2024-01-3107430397core:Non-currentFinancialInstruments2023-01-3107430397dpl:CostSales2023-02-012024-01-3107430397dpl:DistributionCosts2023-02-012024-01-3107430397core:LandBuildings2023-02-012024-01-3107430397core:PlantMachinery2023-02-012024-01-3107430397core:Vehicles2023-02-012024-01-3107430397core:FurnitureFittings2023-02-012024-01-3107430397core:OfficeEquipment2023-02-012024-01-3107430397dpl:AdministrativeExpenses2023-02-012024-01-3107430397core:NetGoodwill2023-02-012024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3107430397dpl:GroupUndertakings2023-02-012024-01-3107430397dpl:ParticipatingInterests2023-02-012024-01-3107430397dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3107430397core:ListedExchangeTraded2023-02-012024-01-3107430397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3107430397core:UnlistedNon-exchangeTraded2023-02-012024-01-3107430397dpl:CostSales2022-02-012023-01-3107430397dpl:DistributionCosts2022-02-012023-01-3107430397core:LandBuildings2022-02-012023-01-3107430397core:PlantMachinery2022-02-012023-01-3107430397core:Vehicles2022-02-012023-01-3107430397core:FurnitureFittings2022-02-012023-01-3107430397core:OfficeEquipment2022-02-012023-01-3107430397dpl:AdministrativeExpenses2022-02-012023-01-3107430397core:NetGoodwill2022-02-012023-01-3107430397core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3107430397dpl:GroupUndertakings2022-02-012023-01-3107430397dpl:ParticipatingInterests2022-02-012023-01-3107430397dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3107430397core:ListedExchangeTraded2022-02-012023-01-3107430397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3107430397core:UnlistedNon-exchangeTraded2022-02-012023-01-3107430397core:NetGoodwill2024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-01-3107430397core:LandBuildings2024-01-3107430397core:PlantMachinery2024-01-3107430397core:Vehicles2024-01-3107430397core:FurnitureFittings2024-01-3107430397core:OfficeEquipment2024-01-3107430397core:AfterOneYear2024-01-3107430397core:WithinOneYear2024-01-3107430397core:ListedExchangeTraded2024-01-3107430397core:UnlistedNon-exchangeTraded2024-01-3107430397core:ShareCapital2024-01-3107430397core:SharePremium2024-01-3107430397core:RevaluationReserve2024-01-3107430397core:OtherReservesSubtotal2024-01-3107430397core:RetainedEarningsAccumulatedLosses2024-01-3107430397core:NetGoodwill2023-01-3107430397core:IntangibleAssetsOtherThanGoodwill2023-01-3107430397core:LandBuildings2023-01-3107430397core:PlantMachinery2023-01-3107430397core:Vehicles2023-01-3107430397core:FurnitureFittings2023-01-3107430397core:OfficeEquipment2023-01-3107430397core:AfterOneYear2023-01-3107430397core:WithinOneYear2023-01-3107430397core:ListedExchangeTraded2023-01-3107430397core:UnlistedNon-exchangeTraded2023-01-3107430397core:ShareCapital2023-01-3107430397core:SharePremium2023-01-3107430397core:RevaluationReserve2023-01-3107430397core:OtherReservesSubtotal2023-01-3107430397core:RetainedEarningsAccumulatedLosses2023-01-3107430397core:NetGoodwill2022-02-0107430397core:IntangibleAssetsOtherThanGoodwill2022-02-0107430397core:LandBuildings2022-02-0107430397core:PlantMachinery2022-02-0107430397core:Vehicles2022-02-0107430397core:FurnitureFittings2022-02-0107430397core:OfficeEquipment2022-02-0107430397core:AfterOneYear2022-02-0107430397core:WithinOneYear2022-02-0107430397core:ListedExchangeTraded2022-02-0107430397core:UnlistedNon-exchangeTraded2022-02-0107430397core:ShareCapital2022-02-0107430397core:SharePremium2022-02-0107430397core:RevaluationReserve2022-02-0107430397core:OtherReservesSubtotal2022-02-0107430397core:RetainedEarningsAccumulatedLosses2022-02-0107430397core:AfterOneYear2023-02-012024-01-3107430397core:WithinOneYear2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3107430397bus:Director12023-02-012024-01-3107430397bus:Director22023-02-012024-01-31

MEDS AT HOME LIMITED

Registered Number
07430397
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

MEDS AT HOME LIMITED
Company Information
for the year from 1 February 2023 to 31 January 2024

Directors

HUSSAIN, Ashraf
IQBAL, Amjid

Registered Address

Unit 26 Delph Industrial Estate, Delph Road
Brierley Hill
DY5 2UA

Registered Number

07430397 (England and Wales)
MEDS AT HOME LIMITED
Balance Sheet as at
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3278-
278-
Current assets
Stocks436,84733,763
Debtors5168,459151,408
Cash at bank and on hand15,25013,040
220,556198,211
Creditors amounts falling due within one year6(168,432)(148,946)
Net current assets (liabilities)52,12449,265
Total assets less current liabilities52,40249,265
Net assets52,40249,265
Capital and reserves
Called up share capital100100
Profit and loss account52,30249,165
Shareholders' funds52,40249,265
The financial statements were approved and authorised for issue by the Board of Directors on 25 October 2024, and are signed on its behalf by:
HUSSAIN, Ashraf
Director
IQBAL, Amjid
Director

Registered Company No. 07430397
MEDS AT HOME LIMITED
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year107
3.Tangible fixed assets

Land & buildings

Plant & machinery

Office Equipment

Total

££££
Cost or valuation
At 01 February 231,86837,19641,53280,596
Additions--371371
At 31 January 241,86837,19641,90380,967
Depreciation and impairment
At 01 February 231,86837,19641,53280,596
Charge for year--9393
At 31 January 241,86837,19641,62580,689
Net book value
At 31 January 24--278278
At 31 January 23----
4.Stocks

2024

2023

££
Raw materials and consumables36,84733,763
Total36,84733,763
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables144,516132,009
Other debtors20,77217,920
Prepayments and accrued income3,1711,479
Total168,459151,408
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables85,03761,002
Taxation and social security2,78614,385
Payments received on account69,84866,331
Other creditors10,7617,228
Total168,432148,946
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.